Methapharm recalls
Methapharm has 1 recall on record with the FDA and USDA, the earliest in 2023 and the latest reported on 3 May 2023. The most frequent reason is manufacturing (cgmp) deviations.
Total recalls1since 2023
Last 12 months0reported
Class I00% of total
Ongoing0latest 3 May 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why methapharm is recalled
Product types
By year
All methapharm recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Pantoprazole sodium for Injection 40 mg*/vial, Single-dose Vial recalled | Methapharm | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.